• EN
  • FR

logo_abyonyx_trans_blanc_3529f.png

  • Home
  • About
    • About
    • Abionyx
    • Management
    • Board of Directors
    • Specialized Committees
      • - Audit Committee
      • - Remuneration Committee
    • Scientific Advisory Board
  • Our Assets
    • Our Assets
    • CER 001
    • CER 002
    • CER 209
  • Media
    • Media
    • Press releases
  • Investors
    • Investors
    • Regulated information
    • Shareholder meeting
    • Investor presentations
    • Corporate presentation
    • Abionyx on stock market
    • Investor Contacts
    • Financial Calendar
  • Slide
  • Slide
  • Investors
  • Regulated information
  • Shareholder meeting
  • Investor presentations
  • Corporate presentation
  • Abionyx on stock market
  • Investor Contacts
  • Financial Calendar

Investor presentation

May 2018 HDL Workshop Conference, San Francisco, May 9 2018 acrobat bleu
March 2018 NASH conference, held by H.C. Wainwright acrobat bleu
November 2017 CERENIS Therapeutics acquires LYPRO Biosciences expanding its HDL strategy into immuno-oncology and chemotherapeutic drug delivery acrobat bleu
September 2017 Rodman & Renshaw conference acrobat bleu
January 2017 ODDO Forum acrobat bleu
October 2016 Corporate presentation acrobat bleu
June 2016 HDL mon coeur (a presentation of the HDL therapy) acrobat bleu
  • Legal notice
  • Contact
© 2021 Abionyx : A new generation biotech company
Back to top